Clearsight Advises Process Stream in its Acquisition by Sikich

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Life Sciences Consulting and Compliance Practices. Clearsight served as exclusive advisor to Process Stream (or “The Company”) in the acquisition of its assets by Sikich, LLP (“Sikich”). This transaction emphasizes Clearsight’s role as a preeminent advisor to the consulting and compliance sectors.

Process Stream is a leading IT Quality & Compliance Consultancy delivering digital transformation services to highly-regulated industries. Headquartered in Princeton, NJ, The Company’s domain and technical experts implement, manage, optimize and ensure enterprise applications are compliant with regulatory requirements across global pharmaceutical, biotechnology, medical device, and insurance organizations. The acquisition of Process Stream will expand Sikich’s consulting capabilities and allow the combined entity to better support clients through a variety of end-to-end tech-enabled services, including a complementary expansion of enterprise resource planning expertise.

Bobby Roy, CEO of Process Stream, commended the deal, “Clearsight’s unparalleled knowledge in the IT Quality & Compliance and Insurtech consulting sectors played a key role in choosing them as our advisor. The entire deal team worked tirelessly and diligently for this great outcome. We’re thrilled to join Sikich and are thankful for Clearsight’s guidance in getting us here.”

John Rakowski, Clearsight Managing Director, added, “Process Stream’s unique integration of people, processes and technology has allowed them to be at the forefront of business process and digital transformation expertise for the regulated industries they serve. Process Stream is a fantastic team of people we are proud to have advised. Sikich’s acquisition creates an even stronger, more diversified platform to better serve its clients and deliver greater value as they embark on their digital journey.”

The Clearsight deal team included John Rakowski, Jim McCabe, Nathan Birhanu and Nitya Chivukula.